Brain Death Clinical Trial
Official title:
Alterations of Conjunctival Microcirculation in Brain Dead Patients
Verified date | March 2016 |
Source | Lithuanian University of Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | Lithuania: Bioethics Committee |
Study type | Observational |
Study hypothesize that ocular microcirculation is reflecting cerebral perfusion. The purpose of this study is to evaluate ocular microcirculation in brain dead patients using side dark field (SDF) videomicroscope and compare it with microcirculatory parameters of healthy volunteers.
Status | Completed |
Enrollment | 22 |
Est. completion date | March 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosed brain dead Exclusion Criteria: - Conjunctival or sublingual mucosa damage |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Lithuania | Lithuanian University of Health Sciences | Kaunas |
Lead Sponsor | Collaborator |
---|---|
Lithuanian University of Health Sciences |
Lithuania,
De Backer D, Hollenberg S, Boerma C, Goedhart P, Büchele G, Ospina-Tascon G, Dobbe I, Ince C. How to evaluate the microcirculation: report of a round table conference. Crit Care. 2007;11(5):R101. — View Citation
De Backer D, Ospina-Tascon G, Salgado D, Favory R, Creteur J, Vincent JL. Monitoring the microcirculation in the critically ill patient: current methods and future approaches. Intensive Care Med. 2010 Nov;36(11):1813-25. doi: 10.1007/s00134-010-2005-3. Epub 2010 Aug 6. Review. — View Citation
Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C. Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express. 2007 Nov 12;15(23):15101-14. — View Citation
Miller MM, Chang T, Keating R, Crouch E, Sable C. Blood flow velocities are reduced in the optic nerve of children with elevated intracranial pressure. J Child Neurol. 2009 Jan;24(1):30-5. doi: 10.1177/0883073808321050. — View Citation
Pranskunas A, Vellinga NA, Pilvinis V, Koopmans M, Boerma EC. Microcirculatory changes during open label magnesium sulphate infusion in patients with severe sepsis and septic shock. BMC Anesthesiol. 2011 Jun 14;11:12. doi: 10.1186/1471-2253-11-12. — View Citation
Ragauskas A, Matijosaitis V, Zakelis R, Petrikonis K, Rastenyte D, Piper I, Daubaris G. Clinical assessment of noninvasive intracranial pressure absolute value measurement method. Neurology. 2012 May 22;78(21):1684-91. doi: 10.1212/WNL.0b013e3182574f50. Epub 2012 May 9. — View Citation
Schaser KD, Settmacher U, Puhl G, Zhang L, Mittlmeier T, Stover JF, Vollmar B, Menger MD, Neuhaus P, Haas NP. Noninvasive analysis of conjunctival microcirculation during carotid artery surgery reveals microvascular evidence of collateral compensation and stenosis-dependent adaptation. J Vasc Surg. 2003 Apr;37(4):789-97. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Microvascular flow index (MFI) of ocular conjunctiva. | Conjunctival convective oxygen transport presented as MFI of small vessels mostly capillaries with diameter cutoff value of 20µm. Images of microcirculation were taken from at least three different points in each ocular conjunctiva and recorded for at least 20 seconds avoiding pressure artifacts. Microcirculation images were obtained using SDF videomicroscopy (Microscan®, Microvision Medicals, Amsterdam, Netherlands). Data recorded to the hard drive of personal computer using AVA 3.0v software (Microvision Medical, Amsterdam, Netherlands). Video clips were then randomly blinded and later analyzed by 2 independent investigators. | After confirmed diagnosis of brain death of any course using cerebral angiography at any time up to 24 hours. | No |
Primary | Total vessel density (TVD) of ocular concunctiva. | Conjunctival microvascular diffusion distance presented as TVD (mm/mm²) of small vessels mostly capillaries with diameter cutoff value of 20µm. Images of microcirculation were taken from at least three different points in each ocular conjunctiva and recorded for at least 20 seconds avoiding pressure artifacts. Microcirculation images were obtained using SDF videomicroscopy (Microscan®, Microvision Medicals, Amsterdam, Netherlands). Data recorded to the hard drive of personal computer using AVA 3.0v software (Microvision Medical, Amsterdam, Netherlands). Video clips were then randomly blinded and later analyzed by 2 independent investigators. | After confirmed diagnosis of brain death of any course using cerebral angiography at any time up to 24 hours. | No |
Primary | Perfused vessel density (PVD) of ocular conjunctiva. | Conjunctival microvascular diffusion distance presented as PVD (mm/mm²) of small vessels mostly capillaries with diameter cutoff value of 20µm. Images of microcirculation were taken from at least three different points in each ocular conjunctiva and recorded for at least 20 seconds avoiding pressure artifacts. Microcirculation images were obtained using SDF videomicroscopy (Microscan®, Microvision Medicals, Amsterdam, Netherlands). Data recorded to the hard drive of personal computer using AVA 3.0v software (Microvision Medical, Amsterdam, Netherlands). Video clips were then randomly blinded and later analyzed by 2 independent investigators | After confirmed diagnosis of brain death of any course using cerebral angiography at any time up to 24 hours. | No |
Secondary | Microvascular flow index (MFI) of sublingual mucosa. | Sublingual mucosa convective oxygen transport presented as MFI of small vessels mostly capillaries with diameter cutoff value of 20µm. Images of microcirculation were taken from at least three different points in sublingual mucosa and recorded for at least 20 seconds avoiding pressure artifacts. Microcirculation images were obtained using SDF videomicroscopy (Microscan®, Microvision Medicals, Amsterdam, Netherlands). Data recorded to the hard drive of personal computer using AVA 3.0v software (Microvision Medical, Amsterdam, Netherlands). Video clips were then randomly blinded and later analyzed by 2 independent investigators. | After confirmed diagnosis of brain death of any course using cerebral angiography at any time up to 24 hours. | No |
Secondary | Total vessel density (TVD) of sublingual mucosa. | Sublingual mucosa microvascular diffusion distance presented as TVD (mm/mm²) of small vessels mostly capillaries with diameter cutoff value of 20µm. Images of microcirculation were taken from at least three different points in sublingual mucosa and recorded for at least 20 seconds avoiding pressure artifacts. Microcirculation images were obtained using SDF videomicroscopy (Microscan®, Microvision Medicals, Amsterdam, Netherlands). Data recorded to the hard drive of personal computer using AVA 3.0v software (Microvision Medical, Amsterdam, Netherlands). Video clips were then randomly blinded and later analyzed by 2 independent investigators. | After confirmed diagnosis of brain death of any course using cerebral angiography at any time up to 24 hours. | No |
Secondary | Perfused vessel density (PVD) of sublingual mucosa. | Sublingual mucosa microvascular diffusion distance presented as PVD (mm/mm²) of small vessels mostly capillaries with diameter cutoff value of 20µm. Images of microcirculation were taken from at least three different points in sublingual mucosa and recorded for at least 20 seconds avoiding pressure artifacts. Microcirculation images were obtained using SDF videomicroscopy (Microscan®, Microvision Medicals, Amsterdam, Netherlands). Data recorded to the hard drive of personal computer using AVA 3.0v software (Microvision Medical, Amsterdam, Netherlands). Video clips were then randomly blinded and later analyzed by 2 independent investigators. | After confirmed diagnosis of brain death of any course using cerebral angiography at any time up to 24 hours. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03765814 -
The Anticipated Organ Donation Approach
|
||
Completed |
NCT02581111 -
Naloxone for Optimizing Hypoxemia Of Lung Donors
|
Phase 2/Phase 3 | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT00998972 -
N-acetyl-cysteine (NAC) and Kidney Graft Function
|
Phase 3 | |
Completed |
NCT04528797 -
Thyroid and Adrenocortical Hormone Replacement in Organ Donors
|
N/A | |
Completed |
NCT03672812 -
The Use of Liraglutide in Brain Death
|
Phase 3 | |
Completed |
NCT04303624 -
Understanding Family Refusal
|
||
Completed |
NCT03098706 -
Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function
|
N/A | |
Not yet recruiting |
NCT04623294 -
Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
|
||
Recruiting |
NCT02102945 -
Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest
|
N/A | |
Terminated |
NCT00675272 -
Organ Donation and Hydrocortisone Treatment
|
N/A | |
Completed |
NCT03262896 -
Neurophysiological Examination in Patients With Brain Death
|
||
Not yet recruiting |
NCT06359119 -
Implementation of Apnoea Test for Patients With Suspected Brain Death
|
||
Recruiting |
NCT05202886 -
"LiverColor": Machine Learning in Liver Photographs
|
N/A | |
Completed |
NCT03281993 -
Apnea Tests as the Methods of Brain Death Diagnosis.
|
N/A | |
Completed |
NCT03179020 -
Donation Network to Optimize Organ Recovery Study
|
N/A | |
Completed |
NCT05070182 -
Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
|
||
Terminated |
NCT03439995 -
Goal of Open Lung Ventilation in Donors
|
N/A | |
Completed |
NCT02525510 -
Deceased Organ Donor Interventions to Protect Kidney Graft Function
|
N/A | |
Completed |
NCT02742857 -
Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury
|
Phase 1 |